Xiaopeng Cai

998 total citations · 1 hit paper
30 papers, 717 citations indexed

About

Xiaopeng Cai is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Xiaopeng Cai has authored 30 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Immunology. Recurrent topics in Xiaopeng Cai's work include Pregnancy and preeclampsia studies (3 papers), Ferroptosis and cancer prognosis (3 papers) and Reproductive System and Pregnancy (3 papers). Xiaopeng Cai is often cited by papers focused on Pregnancy and preeclampsia studies (3 papers), Ferroptosis and cancer prognosis (3 papers) and Reproductive System and Pregnancy (3 papers). Xiaopeng Cai collaborates with scholars based in China, United States and Denmark. Xiaopeng Cai's co-authors include Jingwen Deng, Zhi Chen, Jinli Ding, Chaogang Yang, Jing Yang, Zhongfan Liu, Dongxiao Zhang, Shiyuan Hua, Zhen Du and Min Zhou and has published in prestigious journals such as Journal of Clinical Oncology, Coordination Chemistry Reviews and ACS Applied Materials & Interfaces.

In The Last Decade

Xiaopeng Cai

28 papers receiving 710 citations

Hit Papers

Astaxanthin Activated the Nrf2/HO-1 Pathway to Enhance Au... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaopeng Cai China 13 307 188 154 151 128 30 717
Florian Corvinus Germany 7 264 0.9× 213 1.1× 133 0.9× 397 2.6× 57 0.4× 13 684
Ying Luo China 16 304 1.0× 122 0.6× 103 0.7× 125 0.8× 47 0.4× 62 740
Lu Zhou China 17 314 1.0× 78 0.4× 127 0.8× 133 0.9× 53 0.4× 50 683
Qing Lü China 18 414 1.3× 46 0.2× 173 1.1× 268 1.8× 126 1.0× 36 1.3k
Françoise Caira France 17 481 1.6× 92 0.5× 196 1.3× 321 2.1× 42 0.3× 31 1.0k
Lihua Huang China 11 293 1.0× 41 0.2× 117 0.8× 232 1.5× 215 1.7× 23 709
Elin S. Agoston United States 10 563 1.8× 59 0.3× 85 0.6× 98 0.6× 37 0.3× 11 851
Kwi Hye Koh United States 16 320 1.0× 44 0.2× 137 0.9× 253 1.7× 54 0.4× 21 810

Countries citing papers authored by Xiaopeng Cai

Since Specialization
Citations

This map shows the geographic impact of Xiaopeng Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaopeng Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaopeng Cai more than expected).

Fields of papers citing papers by Xiaopeng Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaopeng Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaopeng Cai. The network helps show where Xiaopeng Cai may publish in the future.

Co-authorship network of co-authors of Xiaopeng Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaopeng Cai. A scholar is included among the top collaborators of Xiaopeng Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaopeng Cai. Xiaopeng Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Fei, et al.. (2025). Covalent organic cages in supramolecular separation. Coordination Chemistry Reviews. 535. 216648–216648. 7 indexed citations
2.
Wang, Qin, Xinyi Zhu, Jing Li, et al.. (2025). HPK1 kinase inhibitor: a sufficient approach to target HPK1 to modulate T cell activation in cancer immunotherapy compared with degraders. Frontiers in Immunology. 16. 1449106–1449106. 1 indexed citations
3.
Cai, Xiaopeng, et al.. (2025). A cysteine-rich transmembrane module peptide GhCYSTM9 is involved in cold stress response. BMC Plant Biology. 25(1). 262–262.
4.
Cai, Xiaopeng, Jingwen Deng, Kaiyue Wang, et al.. (2024). Comprehensive analysis of cuproptosis-related genes involved in immune infiltration and their use in the diagnosis of hepatic ischemia-reperfusion injury: an experimental study. International Journal of Surgery. 111(1). 242–256. 9 indexed citations
5.
Cai, Xiaopeng, et al.. (2023). Laparoscopy-assisted gastrectomy for advanced gastric cancer patients with situs inversus totalis: Two case reports and review of literature. World Journal of Gastrointestinal Surgery. 15(9). 2063–2073.
6.
Cai, Xiaopeng, Huiqiang Cai, Jing Wang, et al.. (2022). Molecular pathogenesis of acetaminophen-induced liver injury and its treatment options. Journal of Zhejiang University SCIENCE B. 23(4). 265–285. 40 indexed citations
7.
Ding, Jinli, Jing Wang, Xiaopeng Cai, et al.. (2022). Granulocyte colony-stimulating factor in reproductive-related disease: Function, regulation and therapeutic effect. Biomedicine & Pharmacotherapy. 150. 112903–112903. 18 indexed citations
9.
Cai, Xiaopeng, Jingwen Deng, Jiaming Zhou, Huiqiang Cai, & Zhi Chen. (2021). Cyclin-dependent kinase 19 upregulation correlates with an unfavorable prognosis in hepatocellular carcinoma. BMC Gastroenterology. 21(1). 377–377. 3 indexed citations
10.
Ding, Jinli, Yan Zhang, Xiaopeng Cai, et al.. (2021). Crosstalk Between Trophoblast and Macrophage at the Maternal-Fetal Interface: Current Status and Future Perspectives. Frontiers in Immunology. 12. 758281–758281. 50 indexed citations
11.
Cai, Xiaopeng, Jiaming Zhou, Jingwen Deng, & Zhi Chen. (2021). Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma. Cancer Cell International. 21(1). 701–701. 12 indexed citations
12.
Tan, Daniel Shao-Weng, António Araújo, Jie Zhang, et al.. (2016). Comparative Efficacy of Ceritinib and Crizotinib as Initial ALK –Targeted Therapies in Previously Treated Advanced NSCLC: An Adjusted Comparison with External Controls. Journal of Thoracic Oncology. 11(9). 1550–1557. 35 indexed citations
13.
Setyawan, Juliana, Hongbo Yang, David Cheng, et al.. (2015). Developing a Risk Score to Guide Individualized Treatment Selection in Attention Deficit/Hyperactivity Disorder. Value in Health. 18(6). 824–831. 6 indexed citations
14.
Zhang, Mingdi, Hui Xue, Xiaopeng Cai, et al.. (2015). Emodin induces apoptosis of human breast cancer cells by modulating the expression of apoptosis-related genes. Oncology Letters. 10(5). 2919–2924. 53 indexed citations
15.
Xue, Hui, Yangchao Chen, Xiaopeng Cai, et al.. (2013). The combined effect of survivin-targeted shRNA and emodin on the proliferation and invasion of ovarian cancer cells. Anti-Cancer Drugs. 24(9). 937–944. 11 indexed citations
17.
Cai, Xiaopeng, et al.. (2012). Breast-Conserving Therapy for Early-Stage Breast Cancer in Chinese Women: A Meta-Analysis of Case-Control Studies. Onkologie. 35(3). 133–139. 3 indexed citations
18.
Cai, Xiaopeng, et al.. (2012). Survivin regulates the expression of VEGF-C in lymphatic metastasis of breast cancer. Diagnostic Pathology. 7(1). 52–52. 23 indexed citations
20.
Tian, Rui, Jianxing Feng, Xiaopeng Cai, & Yong Zhang. (2012). Local chromatin dynamics of transcription factors imply cell-lineage specific functions during cellular differentiation. Epigenetics. 7(1). 55–62. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026